Association of MHC class I expression and lymph node metastasis of gastric carcinoma

Hepato-Gastroenterology

Volumn 60, Issue 123, 2013, Pages 611-615

  Yoshii, Mami ^a   Tanaka, Hiroaki ^a   Ohira, Masaichi ^a   Muguruma, Kazuya ^a   Sakurai, Katsunobu ^a   Kubo, Naoshi ^a   Yashiro, Masakazu ^a   Sawada, Tetsuji ^a   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric carcinoma; Lymph node metastasis; MHC class I

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CARCINOMA;

AGED; CARCINOMA; CELL LINE, TUMOR; CHI-SQUARE DISTRIBUTION; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HLA-A ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LOSS OF HETEROZYGOSITY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STOMACH NEOPLASMS; TIME FACTORS;

EID: 84879581241     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12433     Document Type: Article

References (16)

1. Takayama S, Wakasugi T, Funahashi H, Takeyama H: Strategies for gastric cancer in the modem era. World J Gastrointest Oncol 2010; 2:335-341.
2. Shen YQ, Zhang JQ, Miao FQ, et al.: Relationship between the downregulation of HLA class I antigen and clinicopathological significance in gastric cancer. World J Gastroenterol 2005; 11:3628-3631.
3. Cromme FV, van Bommel PF, Walboomers JM, et al.: Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br J Cancer 1994; 69:1176-1181. (Pubitemid 24161883)
4. Mizukami Y, Kono K, Maruyama T, et al.: Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. Br J Cancer 2008; 99:1462-1467.
5. Kikuchi E, Yamazaki K, Torigoe T, et al.: HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer. Cancer Sci 2007; 98:1424-1430. (Pubitemid 47243535)
6. Watson NF, Ramage JM, Madjd Z, et al.: Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis. Int J Cancer 2006; 118:6-10. (Pubitemid 41681574)
7. Maleno I, Romero JM, Cabrera T, et al.: LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas. Immunogenetics 2006; 58:503-510. (Pubitemid 44025525)
8. Yang Y, Zhang J, Miao F, et al.: Loss of heterozygosity at 6p21 underlying (corrected) HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas. Tissue Antigens 2008; 72:105-114.
9. Ramal LM, Feenstra M, van der Zwan AW, et al.: Criteria to define HLA haplotype loss in human solid tumors. Tissue Antigens 2000; 55:443-448. (Pubitemid 30316155)
10. Yashiro M, Chung YS, Kubo T, Hato F, Sowa M: Differential responses of scirrhous and well-differentiated gastric cancer cells to orthotopic fibroblasts. Br J Cancer 1996; 74:1096-1103. (Pubitemid 26333913)
11. Hippo Y, Yashiro M, Ishii M, et al.: Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 2001; 61:889-895. (Pubitemid 32174397)
12. Shu S, Cochran AJ, Huang RR, Morton DL, Maecker HT: Immune responses in the draining lymph nodes against cancer: implications for immunotherapy. Cancer Metastasis Rev 2006; 25:233-242. (Pubitemid 43886398)
13. Maehara Y, Tomisaki S, Oda S, et al.: Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer. Int J Cancer 1997; 74:224-228. (Pubitemid 27234515)
14. Seliger B: Novel insights into the molecular mechanisms of HLA class I abnormalities. Cancer Immunol Immunother 2012; 61:249-254.
15. Seliger B: Molecular mechanisms of MHC class I abnormalities and APM components in human tumors. Cancer Immunol Immunother 2008; 57:1719-1726.
16. Wang XC, Zhang JQ, Shen YQ, Miao FQ, Xie W: Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer. J Exp Clin Cancer Res 2006; 25:115-119.